InvestorsHub Logo
Followers 80
Posts 1038
Boards Moderated 0
Alias Born 06/26/2014

Re: Jt0082 post# 219323

Tuesday, 10/15/2019 8:02:48 AM

Tuesday, October 15, 2019 8:02:48 AM

Post# of 429135

Our DCF assumes an 11% WACC, consistent with our valuation of other biopharma companies in a similar stage of clinical development with an upcoming commercial launch,




That says it all....clinical development and upcoming commercial launch and that is not the case
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News